- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05350267
Changing Health and Lifestyle Behaviors of Offspring Following Maternal Bariatric Surgery (HALO-2)
November 13, 2025 updated by: Children's Hospital Medical Center, Cincinnati
This is the Phase 2 pilot/feasibility randomized controlled trial of HALO (Health And Lifestyle Behaviors In Offspring), a parent-led behavioral intervention targeting a high-risk pediatric population (i.e., residing offspring ages 6-12; body mass index > the 70th and < 120% of the 95th percentiles of mothers with severe obesity) that is uniquely well-timed, when mothers are highly engaged in behavior change and losing weight during the first year following bariatric surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Female caregivers with a biological child (either sex) aged 6-12 years
- Caregiver is 3-12 months post undergoing a non-device based bariatric surgical procedure
- Caregiver is able to read, write, and speak in English
- Child has a BMI > the 70th and < 120% of the 95th percentile
- Child not currently engaged in weight management (behavioral, pharmacologic)
- Child has no chronic medical conditions or developmental disabilities
- Child resides in her home > 75% of the time
- Child is willing to participate
Exclusion criteria:
- Female caregiver is not pregnant at time of enrollment
- Must not live >75 miles from Cincinnati Children's Hospital Main Campus.
- Child BMI is > 120% of the 95th percentile
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
HALO is a mixed-delivery intervention (online learning, digital technologies, telehealth visits) co-designed with mothers that (a) uniquely tailors intervention content to integrate post-bariatric surgery guidelines to recommendations to reduce child obesity risk, (b) teaches mothers evidence-based parenting behaviors to support intergenerational lifestyle and home food environment changes, and (c) addresses unique barriers to family-level change identified by mothers post-bariatric surgery.
|
Health and Lifestyle Behaviors in Offspring, or "HALO" is designed for mothers who recently had bariatric surgery who have a school-aged child.
HALO focuses on providing each mother with education and parenting strategies to improve her child's healthy lifestyle behaviors, such as her child's eating and physical activity, while she is engaged in her own lifestyle behavior change after bariatric surgery.
|
|
Active Comparator: Enhanced Standard of Care
The comparator group will receive monthly mailings of publicly available and age-appropriate handouts on healthy eating, physical activity, screen time, and healthy sleep habits
|
The comparator group will receive monthly mailings of publicly available and age-appropriate handouts on healthy eating, physical activity, screen time, and healthy sleep habits
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preliminary Efficacy - Change in child body mass index standardized for age/sex from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Trained assessors will measure child height/weight using a standardized protocol.
These measurements will be converted to body mass index (kg/m^2) and then standardized by child age and sex
|
baseline to 26 weeks (post-treatment)
|
|
Preliminary Efficacy - Change in child body mass index standardized for age/sex from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Trained assessors will measure child height/weight using a standardized protocol.
These measurements will be converted to body mass index (kg/m^2) and then standardized by child age and sex
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary - Change in child daily intake of total kcals, and kcals from red foods, sugar-sweetened beverages, and fruits and vegetables from baseline to 26 weeks (post-treatment) using a 3-day dietary recall
Time Frame: baseline to 26 weeks (post-treatment)
|
Child dietary intake (mother-reported) will be assessed by a registered dietician via 3 scheduled 24-hour phone recalls (2 weekdays, 1 weekend) over a 2 week period using a multiple pass method.
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in child daily intake of total kcals, and kcals from red foods, sugar-sweetened beverages, and fruits and vegetables from baseline to 52 weeks (6-month follow-up) using a 3-day dietary recall
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Child dietary intake (mother-reported) will be assessed by a registered dietician via 3 scheduled 24-hour phone recalls (2 weekdays, 1 weekend) over a 2 week period using a multiple pass method.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Secondary - Change in child minutes of moderate to vigorous physical activity (MVPA) from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Child minutes of moderate to vigorous physical activity will be assessed via a waist-worn actigraph accelerometer for 7 days, with data processed via validated scoring protocols
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in child minutes of moderate to vigorous physical activity (MVPA) from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Child minutes of moderate to vigorous physical activity will be assessed via a waist-worn actigraph accelerometer for 7 days, with data processed via validated scoring protocols
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Secondary - Change in mother-reported child feeding practices of restriction, pressure to eat, perceived responsibility, and monitoring from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Mothers will complete the Child Feeding Questionaire with validated scale scores in the areas of restriction, pressure to eat, perceived responsibility, and monitoring.
Items are rated on a 5-point Likert scale, with subscales scored as the average.
Higher scores indicate greater use of each feeding strategy.
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in mother-reported child feeding practices of restriction, pressure to eat, perceived responsibility, and monitoring from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Mothers will complete the Child Feeding Questionaire with validated scale scores in the areas of restriction, pressure to eat, perceived responsibility, and monitoring.
Items are rated on a 5-point Likert scale, with subscales scored as the average.
Higher scores indicate greater use of each feeding strategy.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Secondary - Change in child hours of screen time from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Mother-report of her child's leisure-time spent on a "typical week-day" using 3 types of screens (TV, computer/video-games, internet/electronic media).
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in child hours of screen time from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Mother-report of her child's leisure-time spent on a "typical week-day" using 3 types of screens (TV, computer/video-games, internet/electronic media).
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Secondary - Change in physical home food environment total kcals, and kcals from sugar-sweetened beverages, snack foods, fruits, and vegetables from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Trained assessors will conduct an open home food inventory.
Assessors record the presence of food or beverage items (size and quantity) located in the kitchen and secondary food storage areas (e.g., pantry, basement refrigerator).
Foods/beverages without indication of size on packaging will be weighed.
Full package size for partially consumed items will be recorded.
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in physical home food environment total kcals, and kcals from sugar-sweetened beverages, snack foods, fruits, and vegetables from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Trained assessors will conduct an open home food inventory.
Assessors record the presence of food or beverage items (size and quantity) located in the kitchen and secondary food storage areas (e.g., pantry, basement refrigerator).
Foods/beverages without indication of size on packaging will be weighed.
Full package size for partially consumed items will be recorded.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Secondary - Change in mother use of encouragement/modeling from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Scale from the Neighborhood Impact on Kids Study will be used to assess 7 healthful eating behaviors (i.e., fruits, vegetables, low-fat snacks).
Each item is rated on a Likert scale from 1 (never) to 5 (always), with the average taken across the 7 items.
Higher scores mean more healthful modeling.
|
baseline to 26 weeks (post-treatment)
|
|
Secondary - Change in mother use of encouragement/modeling from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Scale from the Neighborhood Impact on Kids Study will be used to assess 7 healthful eating behaviors (i.e., fruits, vegetables, low-fat snacks).
Each item is rated on a Likert scale from 1 (never) to 5 (always), with the average taken across the 7 items.
Higher scores mean more healthful modeling.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in maternal percent weight loss and body mass index from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Trained assessors will measure mothers' weight and height using a standardized protocol which will be used to calculate maternal percent weight loss and body mass index (kg/m^2).
|
baseline to 26 weeks (post-treatment)
|
|
Change in maternal percent weight loss and body mass index from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Trained assessors will measure mothers' weight and height using a standardized protocol which will be used to calculate maternal percent weight loss and body mass index (kg/m^2).
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Change in maternal total kcals from baseline to 26 weeks (post-treatment) using a 3-day dietary recall
Time Frame: baseline to 26 weeks (post-treatment)
|
Mother-reported dietary intake will be assessed by a registered dietician via 3 scheduled 24-hour phone recalls (2 weekdays and 1 weekend) over a 2-week period using the multiple-pass method to measure total kcals.
|
baseline to 26 weeks (post-treatment)
|
|
Change in maternal total kcals from baseline to 52 weeks (6-month follow-up) using a 3-day dietary recall
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Mother-reported dietary intake will be assessed by a registered dietician via 3 scheduled 24-hour phone recalls (2 weekdays and 1 weekend) over a 2-week period using the multiple-pass method to measure total kcals.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Change in mother's minutes of moderate to vigorous physical activity from baseline to 26 weeks (post-treatment)
Time Frame: baseline to 26 weeks (post-treatment)
|
Mother minutes of moderate to vigorous physical activity will be assessed via a waist-worn actigraph accelerometer for 7 days, with data processed via validated scoring protocols.
|
baseline to 26 weeks (post-treatment)
|
|
Change in mother's minutes of moderate to vigorous physical activity from baseline to 52 weeks (6-month follow-up)
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Mother minutes of moderate to vigorous physical activity will be assessed via a waist-worn actigraph accelerometer for 7 days, with data processed via validated scoring protocols.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Change in child emotional functioning from baseline to 26 weeks (post-treatment) using Sizing Me Up
Time Frame: baseline to 26 weeks (post-treatment)
|
Sizing Me Up is a child-reported weight-related quality of life measure validated for youth (ages 5-13) that assesses a child's thoughts and experiences in context of his/her "size".
Lowered scores on the 4-item child emotional functioning subscale (how their size makes them feel [mad, sad, worried, and frustrated]) will be monitored.
Raw scores will be transformed to a 0-100 scale, with higher scores representing better emotional functioning.
|
baseline to 26 weeks (post-treatment)
|
|
Change in child emotional functioning from baseline to 52 weeks (6-month follow-up) using Sizing Me Up
Time Frame: baseline to 52 weeks (6-month follow-up post-treatment)
|
Sizing Me Up is a child-reported weight-related quality of life measure validated for youth (ages 5-13) that assesses a child's thoughts and experiences in context of his/her "size".
Lowered scores on the 4-item child emotional functioning subscale (how their size makes them feel [mad, sad, worried, and frustrated]) will be monitored.
Raw scores will be transformed to a 0-100 scale, with higher scores representing better emotional functioning.
|
baseline to 52 weeks (6-month follow-up post-treatment)
|
|
Attendance/Participation rates
Time Frame: baseline to 26 weeks (post-treatment) and 52 weeks (6-month follow-up)
|
Thresholds will be used as guides to evaluate whether study achieved goals (e.g., percent) for enrollment (at least 85 percent eligible approached), representativeness (at least 30 percent Non-White), retention (at least 80 percent mother/child dyads in treatment group complete 16-week intervention), and data completion (at least 80 percent complete all 3 assessements).
|
baseline to 26 weeks (post-treatment) and 52 weeks (6-month follow-up)
|
|
Implementation - Fidelity
Time Frame: baseline to 26 weeks (post-treatment)
|
Thresholds will be used as guides to evaluate whether treatment arm delivered as intended.
Fidelity checklists created specifically for each intervention session based on intervention manual.
|
baseline to 26 weeks (post-treatment)
|
|
Implementation - Usability/Satisfaction
Time Frame: baseline to 26 weeks (post-treatment)
|
Thresholds will be used a guides to evaluate whether treatment arm mothers' ratings of content accessibility, acceptability, usability, and satisfaction of the HALO program via Likert ratings (Scale 1-5) with higher scores indicating greater usability and satisfaction.
Thresholds are mean/item ratings greater than or equal to 4.
|
baseline to 26 weeks (post-treatment)
|
|
Time needed for intervention
Time Frame: baseline to 26 weeks (post-treatment)
|
For the treatment arm.
time will be assessed in three ways.
Time stamp of time watching sessions videos will be recorded.
Treatment sessions will be timed to determine average length of time needed.
Number of weeks to complete all sessions will be tracked to determine the average length of time needed to execute intervention.
|
baseline to 26 weeks (post-treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Margaret H Zeller, PhD, Cincinnati Chidren's Hospital Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2022
Primary Completion (Actual)
March 10, 2025
Study Completion (Actual)
March 19, 2025
Study Registration Dates
First Submitted
April 22, 2022
First Submitted That Met QC Criteria
April 22, 2022
First Posted (Actual)
April 28, 2022
Study Record Updates
Last Update Posted (Estimated)
November 14, 2025
Last Update Submitted That Met QC Criteria
November 13, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-0601
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Prior to sharing, all data will be de-identified in a HIPAA-compliant fashion.
Data sets will be carefully reviewed to make sure that information such as age and sex cannot be used to gather additional information that could potentially identify individual subjects.
All categorical demographic variables will be collapsed into categories large enough so that combinations of demographic categories for age, sex, geographic location, etc., will have 10 or more individuals in each cell.
All modalities of data will be shared, including raw and aggregate data.
Descriptors for all variables shared will be included to prevent misuse or confusion.
Any analytical methods utilized to assess the data will be defined in shared formats.
IPD Sharing Time Frame
12 months following completion of the study
IPD Sharing Access Criteria
PI will provide information
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Childhood
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on HALO
-
Medtronic - MITGCompleted
-
Hospital Sao JoaoCompletedGastric Dysplasia | NeoplasiaPortugal
-
Dartmouth-Hitchcock Medical CenterCompletedLung Cancer | Bladder Cancer | Cancer of Head and Neck | Nicotine Dependence, Other Tobacco ProductUnited States
-
Poole Hospital NHS Foundation TrustTerminated
-
ScitonCompletedDyschromia | Photodamaged Skin
-
University Hospitals Cleveland Medical CenterCompleted
-
Zeit Medical, Inc.Not yet recruitingStroke | Ischemic Stroke | Acute Ischemic Stroke
-
Curonix LLCWithdrawn
-
Blue Halo Biomedical, LLCRecruitingUrinary RetentionUnited States
-
ScitonCompleted